headaches.
The patient had a past history of pulmonary embolism and was taking warfarin. She was also taking phenytoin to prevent seizures and long-term amoxycillin for cerebral abscesses.
This infection had been slow to resolve so 36 hours before her presentation, clindamycin 450 mg three times daily had been added to her treatment.
Physical examination was unremarkable and her warfarin and phenytoin concentrations were in the therapeutic range. only one case has been published recently 2 , the remaining few coming from the 1970s. 3, 4 The recent case occurred with low-dose oral clindamycin while the earlier cases involved parenteral clindamycin. Hepatotoxicity resolved in all cases after stopping clindamycin, but unlike our patient the resolution took several weeks. Liver biopsies showed mixed hepatocellular and portal damage. 2, 3 The hepatotoxicity is probably idiosyncratic since patients with underlying liver disease who were given clindamycin had no exacerbation of liver dysfunction. 5 In summary, acute hepatotoxicity is a rare complication of clindamycin that may be seen more often with its increasing use. Clinicians should have a low threshold for checking liver function in their patients, particularly if they become unwell while taking clindamycin.
